23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
20.79%
Revenue growth exceeding 1.5x Insurance - Life median of 5.29%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
20.79%
Gross profit growth exceeding 1.5x Insurance - Life median of 5.20%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
-120.47%
Negative EBIT growth while Insurance - Life median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-120.47%
Negative operating income growth while Insurance - Life median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-109.70%
Negative net income growth while Insurance - Life median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-109.69%
Negative EPS growth while Insurance - Life median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-109.69%
Negative diluted EPS growth while Insurance - Life median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
15.99%
OCF growth of 15.99% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
15.99%
FCF growth of 15.99% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
304.60%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 101.45%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
69.89%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 18.25%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
67.37%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 3.75%. Joel Greenblatt might see a short-term competitive advantage at play.
No Data
No Data available this quarter, please select a different quarter.
57.32%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 29.54%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
77.43%
3Y OCF/share growth > 1.5x Insurance - Life median of 5.77%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
-176.65%
Negative 10Y net income/share CAGR vs. Insurance - Life median of 0.00%. Seth Klarman might see a fundamental problem if peers maintain growth.
-123.89%
Negative 5Y CAGR while Insurance - Life median is 0.00%. Seth Klarman might see a specific weakness if peers maintain profitable expansions.
-117.68%
Negative 3Y CAGR while Insurance - Life median is -8.81%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
269.33%
Equity/share CAGR exceeding 1.5x Insurance - Life median of 29.74% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
10.38%
5Y equity/share CAGR near Insurance - Life median. Charlie Munger finds it normal mid-term expansion for the industry.
10.57%
3Y equity/share CAGR > 1.5x Insurance - Life median of 1.43%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.15%
Below 50% of Insurance - Life median. Jim Chanos suspects stagnation or limited capital availability for expansions.
-4.03%
Negative BV/share change while Insurance - Life median is 3.38%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
-2.32%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-2.84%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.